The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage.
暂无分享,去创建一个
D. Ron | S. Miller | H. Harding | B. Popko | Wensheng Lin | S. Bailey | H. Ho
[1] F. LaFerla,et al. Regional hypomyelination and dysplasia in transgenic mice with astrocyte-directed expression of interferon-γ , 2000, Journal of Molecular Neuroscience.
[2] B. Popko,et al. The effects of interferon-γ on the central nervous system , 1997, Molecular Neurobiology.
[3] T. Owens,et al. Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1‐deficient mice with experimental autoimmune encephalomyelitis , 2006, Immunology.
[4] S. Nakae,et al. IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.
[5] R. Kapoor. Neuroprotection in multiple sclerosis: therapeutic strategies and clinical trial design , 2006, Current opinion in neurology.
[6] Mark A Sussman,et al. Endoplasmic Reticulum Stress Gene Induction and Protection From Ischemia/Reperfusion Injury in the Hearts of Transgenic Mice With a Tamoxifen-Regulated Form of ATF6 , 2006, Circulation research.
[7] B. Popko,et al. Suppressor of Cytokine Signaling 1 Expression Protects Oligodendrocytes from the Deleterious Effects of Interferon-γ , 2006, The Journal of Neuroscience.
[8] Markus Mohrs,et al. Activation of the integrated stress response during T helper cell differentiation , 2006, Nature Immunology.
[9] D. Ron,et al. Interferon-γ inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress , 2006 .
[10] Yaniv Ziv,et al. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. , 2006, The Journal of clinical investigation.
[11] E. Frohman,et al. Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.
[12] Junying Yuan,et al. Cellular response to endoplasmic reticulum stress: a matter of life or death , 2006, Cell Death and Differentiation.
[13] H. Wootz,et al. ER stress and neurodegenerative diseases , 2006, Cell Death and Differentiation.
[14] Randal J. Kaufman,et al. Divergent Roles of IRE1α and PERK in the Unfolded Protein Response , 2006 .
[15] D. Ron,et al. Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. , 2006, Brain : a journal of neurology.
[16] R. Kaufman,et al. Divergent roles of IRE1alpha and PERK in the unfolded protein response. , 2006, Current molecular medicine.
[17] B. Popko,et al. Suppressor of cytokine signaling 1 expression protects oligodendrocytes from the deleterious effects of interferon-gamma. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[18] G. Kollias,et al. Apoptosis of Oligodendrocytes via Fas and TNF-R1 Is a Key Event in the Induction of Experimental Autoimmune Encephalomyelitis1 , 2005, The Journal of Immunology.
[19] Ying Wang,et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.
[20] K. Mori,et al. Tumor Necrosis Factor α (TNFα) Induces the Unfolded Protein Response (UPR) in a Reactive Oxygen Species (ROS)-dependent Fashion, and the UPR Counteracts ROS Accumulation by TNFα* , 2005, Journal of Biological Chemistry.
[21] C. Polman,et al. Current trials in multiple sclerosis: established evidence and future hopes , 2005, Current opinion in neurology.
[22] D. Ron,et al. Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-γ , 2005, The Journal of cell biology.
[23] Taking Two TRAILS , 2005, Neuron.
[24] S. Khoury,et al. Cytokines in multiple sclerosis: from bench to bedside. , 2005, Pharmacology & therapeutics.
[25] C. Matute,et al. Multiple sclerosis: novel perspectives on newly forming lesions , 2005, Trends in Neurosciences.
[26] T. Owens,et al. The changing face of cytokines in the brain: perspectives from EAE. , 2005, Current pharmaceutical design.
[27] C. Proud. eIF2 and the control of cell physiology. , 2005, Seminars in cell & developmental biology.
[28] K. Mori,et al. Tumor necrosis factor alpha (TNFalpha) induces the unfolded protein response (UPR) in a reactive oxygen species (ROS)-dependent fashion, and the UPR counteracts ROS accumulation by TNFalpha. , 2005, The Journal of biological chemistry.
[29] Kai Long,et al. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. , 2005, Science.
[30] K. McCarthy,et al. Interferon- (cid:1) Induced Medulloblastoma in the Developing Cerebellum , 2004 .
[31] R. Banati,et al. Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease , 2004, Brain Research Reviews.
[32] V. Perry,et al. Cytokine‐induced enhancement of autoimmune inflammation in the brain and spinal cord: implications for multiple sclerosis , 2004, Neuropathology and applied neurobiology.
[33] S. LeVine,et al. Immunohistochemical localization of phosphorylated protein kinase R and phosphorylated eukaryotic initiation factor‐2α in the central nervous system of SJL mice with experimental allergic encephalomyelitis , 2004, Journal of neuroscience research.
[34] K. Selmaj,et al. Microarray gene expression profiling of chronic active and inactive lesions in multiple sclerosis , 2004, Clinical Neurology and Neurosurgery.
[35] D. Scheuner,et al. Cytoprotection by pre‐emptive conditional phosphorylation of translation initiation factor 2 , 2004, The EMBO journal.
[36] K. McCarthy,et al. Interferon-gamma induced medulloblastoma in the developing cerebellum. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[37] H. Mühl,et al. Anti-inflammatory properties of pro-inflammatory interferon-gamma. , 2003, International immunopharmacology.
[38] H. Okano,et al. Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination , 2003, Neuroscience Research.
[39] J. Bonventre,et al. Protection of Renal Epithelial Cells against Oxidative Injury by Endoplasmic Reticulum Stress Preconditioning Is Mediated by ERK1/2 Activation* , 2003, Journal of Biological Chemistry.
[40] R. Paules,et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. , 2003, Molecular cell.
[41] Masataka Mori,et al. Endoplasmic reticulum stress and diabetes mellitus. , 2003, Internal medicine.
[42] Robin J. M. Franklin,et al. Why does remyelination fail in multiple sclerosis? , 2002, Nature Reviews Neuroscience.
[43] S. Miller,et al. De Novo Central Nervous System Processing of Myelin Antigen Is Required for the Initiation of Experimental Autoimmune Encephalomyelitis1 , 2002, The Journal of Immunology.
[44] M. Ameloot,et al. Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions. , 2002, Critical reviews in immunology.
[45] G. Comi,et al. Intrathecal Delivery of IFN-γ Protects C57BL/6 Mice from Chronic-Progressive Experimental Autoimmune Encephalomyelitis by Increasing Apoptosis of Central Nervous System-Infiltrating Lymphocytes1 , 2001, The Journal of Immunology.
[46] D. Ron,et al. Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival. , 2001, Molecular cell.
[47] H. Okano,et al. Caspase-11 Mediates Oligodendrocyte Cell Death and Pathogenesis of Autoimmune-Mediated Demyelination , 2001, The Journal of experimental medicine.
[48] P. Ye,et al. Interferon-γ Protects against Cuprizone-Induced Demyelination , 2000, Molecular and Cellular Neuroscience.
[49] D. Ron,et al. Perk is essential for translational regulation and cell survival during the unfolded protein response. , 2000, Molecular cell.
[50] J. Miyazaki,et al. Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune‐mediated demyelination , 2000, The EMBO journal.
[51] B. Popko,et al. Major histocompatibility complex heavy chain accumulation in the endoplasmic reticulum of oligodendrocytes results in myelin abnormalities , 2000, Journal of neuroscience research.
[52] P. Ye,et al. Interferon-gamma protects against cuprizone-induced demyelination. , 2000, Molecular and cellular neurosciences.
[53] B. Trapp,et al. Pathogenesis of tissue injury in MS lesions , 1999, Journal of Neuroimmunology.
[54] P. Morell,et al. Myelin Formation, Structure and Biochemistry , 1999 .
[55] R. Simone,et al. Interferon-γ in Progression to Chronic Demyelination and Neurological Deficit Following Acute EAE , 1998, Molecular and Cellular Neuroscience.
[56] S. Sakoda,et al. The development of autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein is associated with an upregulation of both proinflammatory and immunoregulatory cytokines in the central nervous system. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[57] W. Cowden,et al. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. , 1996, Journal of immunology.
[58] T. Owens,et al. Interferon‐γ confers resistance to experimental allergic encephalomyelitis , 1996, European journal of immunology.
[59] B. Popko,et al. Targeted CNS Expression of Interferon-γ in Transgenic Mice Leads to Hypomyelination, Reactive Gliosis, and Abnormal Cerebellar Development , 1996, Molecular and Cellular Neuroscience.
[60] L. Steinman,et al. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). , 1996, Journal of immunology.
[61] A. Warrington,et al. The oligodendrocyte and its many cellular processes. , 1993, Trends in cell biology.
[62] W. Welch. Mammalian stress response: cell physiology, structure/function of stress proteins, and implications for medicine and disease. , 1992, Physiological reviews.
[63] W. Hickey,et al. T‐lymphocyte entry into the central nervous system , 1991, Journal of neuroscience research.
[64] P. Molinoff,et al. Basic Neurochemistry: Molecular, Cellular and Medical Aspects , 1989 .
[65] R. Hirsch,et al. Treatment of multiple sclerosis with gamma interferon , 1987, Neurology.